Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4446468 | 0.86 | MEN1 (0.43) | KMT2AMEN1MAPTALDH1A1GAA | |
| SCHEMBL15871413 | 0.85 | KMT2A (0.51) | KMT2AMEN1POLBMAPTNPSR1 | |
| SCHEMBL31482562 | 0.85 | KMT2A (0.54) | KMT2AMEN1POLBMAPTNPSR1 | |
| SCHEMBL3890445 | 0.85 | KMT2A (0.54) | KMT2AMEN1POLBMAPTNPSR1 | |
| SCHEMBL4455971 | 0.83 | CYP3A4 (0.41) | CYP3A4 | |
| SCHEMBL28672462 | 0.82 | MEN1 (0.49) | KMT2AMEN1POLBMAPTNPSR1 | |
| SCHEMBL9441162 | 0.82 | KMT2A (0.53) | KMT2AMEN1POLBMAPTNPSR1 | |
| SCHEMBL9441105 | 0.82 | KMT2A (0.49) | KMT2AMEN1POLBMAPTNPSR1 | |
| SCHEMBL4457990 | 0.82 | ALDH1A1 (0.51) | KMT2AMEN1POLBMAPTNPSR1 | |
| SCHEMBL18486629 | 0.80 | MEN1 (0.61) | KMT2AMEN1POLBNPSR1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10550241-B2 | Polytrimethylene terephthalate composition, polyester fiber, and methods for producing the same | TEIJIN FRONTIER CO., LTD. (JP) | 2020-02-04 | — | — | US | disclosed |
| EP-3249012-B1 | POLYTRIMETHYLENE TEREPHTHALATE COMPOSITION, POLYESTER FIBERS, AND METHOD FOR PRODUCING SAME | TEIJIN FRONTIER CO LTD (JP) | 2019-08-21 | — | — | EP | disclosed |
| CN-107109040-B | Polytrimethylene terephthalate composition, polyester fiber and its manufacturing method | 帝人富瑞特株式会社 | 2019-06-28 | — | — | CN | disclosed |
| US-20180265667-A1 | POLYTRIMETHYLENE TEREPHTHALATE COMPOSITION, POLYESTER FIBER, AND METHODS FOR PRODUCING THE SAME | TEIJIN LIMITED (JP) | 2018-09-20 | — | — | US | disclosed |
| CN-106029733-B | Polyethylene-2, 6-naphthalate composition having excellent blow moldability and molded article thereof | 帝人株式会社 | 2018-09-07 | — | — | CN | disclosed |
| US-10017629-B2 | Polyethylene-2,6-naphthalate composition with excellent blow moldability, and molded product thereof | TEIJIN LIMITED (JP) | 2018-07-10 | — | — | US | disclosed |
| EP-3109271-B1 | POLYETHYLENE-2,6-NAPHTHALATE COMPOSITION WITH EXCELLENT BLOW MOLDABILITY, AND MOLDED PRODUCT THEREOF | TEIJIN LTD (JP) | 2018-03-28 | — | — | EP | disclosed |
| EP-3249012-A1 | POLYTRIMETHYLENE TEREPHTHALATE COMPOSITION, POLYESTER FIBERS, AND METHOD FOR PRODUCING SAME | Teijin Limited (JP) | 2017-11-29 | — | — | EP | disclosed |
| CN-107109040-A | Polytrimethylene terephthalate composition, polyester fiber and its manufacture method | 帝人株式会社 | 2017-08-29 | — | — | CN | disclosed |
| EP-3109271-A1 | POLYETHYLENE-2,6-NAPHTHALATE COMPOSITION WITH EXCELLENT BLOW MOLDABILITY, AND MOLDED PRODUCT THEREOF | Teijin Limited (JP) | 2016-12-28 | — | — | EP | disclosed |
| US-20090163444-A1 | PHOSPHO-INDOLES AS HIV INHIBITORS | IDENIX PHARMACEUTICALS LLC | 2009-06-25 | — | — | US | disclosed |
| US-20090163444-A1 | PHOSPHO-INDOLES AS HIV INHIBITORS | IDENIX PHARMACEUTICALS LLC | 2009-06-25 | — | — | US | disclosed |
| US-7534809-B2 | Phospho-indoles as HIV inhibitors | IDENIX PHARMACEUTICALS, INC. (US) | 2009-05-19 | — | — | US | disclosed |
| US-7534809-B2 | Phospho-indoles as HIV inhibitors | IDENIX PHARMACEUTICALS, INC. (US) | 2009-05-19 | — | — | US | disclosed |
| EP-1961757-A1 | Phosphoindoles as HIV inhibitors | IDENIX Pharmaceuticals, Inc. (US) | 2008-08-27 | — | — | EP | disclosed |
| US-20080146733-A1 | Hydrogenation catalyst composition and method for hydrogenation of conjugated diene polymer | TSRC CORPORATION (TW) | 2008-06-19 | — | — | US | disclosed |
| EP-0391415-B1 | Naphthalocyanine compounds and production thereof | ORIENT CHEMICAL IND (JP) | 1995-03-29 | — | — | EP | disclosed |
| US-5149847-A | Phosphoryl-substituted 2,3-dicyanonaphthalene intermediate | ORIENT CHEMICAL INDUSTRIES, LTD. (JP) | 1992-09-22 | — | — | US | disclosed |
| US-5064951-A | NAPHTHALOCYANINE COMPOUND AND PRODUCTION THEREOF | ORIENT CHEMICAL INDUSTRIES, LTD. (JP) | 1991-11-12 | — | — | US | disclosed |
| EP-0391415-A2 | Naphthalocyanine compounds and production thereof | ORIENT CHEMICAL INDUSTRIES, LTD. (JP) | 1990-10-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090163444-A1 | PHOSPHO-INDOLES AS HIV INHIBITORS | IDO1, PPP5C, INMT | KMT2A 1767/4885MEN1 3483/4885POLB 712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.